PMC:7271924 / 26189-26461 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T515","span":{"begin":214,"end":227},"obj":"NCBITaxon:11118"},{"id":"T516","span":{"begin":240,"end":250},"obj":"SP_7"},{"id":"T517","span":{"begin":263,"end":271},"obj":"SP_7"},{"id":"T10854","span":{"begin":214,"end":227},"obj":"NCBITaxon:11118"},{"id":"T63794","span":{"begin":240,"end":250},"obj":"SP_7"},{"id":"T61390","span":{"begin":263,"end":271},"obj":"SP_7"}],"text":"In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"670","span":{"begin":214,"end":227},"obj":"Species"},{"id":"671","span":{"begin":240,"end":250},"obj":"Species"},{"id":"673","span":{"begin":263,"end":271},"obj":"Disease"}],"attributes":[{"id":"A670","pred":"tao:has_database_id","subj":"670","obj":"Tax:11118"},{"id":"A671","pred":"tao:has_database_id","subj":"671","obj":"Tax:2697049"},{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T87","span":{"begin":240,"end":244},"obj":"Disease"},{"id":"T88","span":{"begin":263,"end":271},"obj":"Disease"}],"attributes":[{"id":"A87","pred":"mondo_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A88","pred":"mondo_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T339","span":{"begin":81,"end":83},"obj":"Chemical"},{"id":"T340","span":{"begin":107,"end":109},"obj":"Chemical"},{"id":"T341","span":{"begin":168,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A339","pred":"chebi_id","subj":"T339","obj":"http://purl.obolibrary.org/obo/CHEBI_73585"},{"id":"A340","pred":"chebi_id","subj":"T340","obj":"http://purl.obolibrary.org/obo/CHEBI_73585"},{"id":"A341","pred":"chebi_id","subj":"T341","obj":"http://purl.obolibrary.org/obo/CHEBI_33232"}],"text":"In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T198","span":{"begin":0,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In view of these investigations, the authors of this paper regard enteric-coated LF as superior to regular LF supplements with respect to bioavailability and potential application for the prevention or therapy for coronaviruses such as the SARS-Cov-2 involved in COVID-19."}